TechLife Capital is a growth equity fund specialized in the Healthcare and Technology industries.
It is managed by an independent management company approved by the French AMF (Autorité des Marchés Financiers), having received the Innovation Financing label from the French Ministry of Economy and Finance (Tibi initiative).
TechLife Capital is dedicated to two main industries, Healthcare and Technology. The overlapping universe HealthTech and TechHealth is also essential, considering that technology is more and more critical in healthcare
These two industries are deep, global, relatively acyclical, buoyed by long term trends. French players could have a significant credibility at European or at global levels, considering the expertise of French engineers and developers, and the quality of French medical and pharmaceutical professionals. Therefore, the investment opportunities are numerous and attractive.
9 sectors have been targeted within these industries:
Healthcare: pharmaceutical industry, medical services, medical devices
Technology: software, services, solutions
Health tech: health software, medtech, health data
An expert approach
Nevertheless, these industries remain complex, with many interconnected business models and constituents, and potential government regulations. It is important to try to develop an expert approach.
The three partners at TechLife Capital have covered the Healthcare and Technology industries for more than 20 years, have complementary Corporate and Private Equity Investment experiences, and have already invested in most sectors of these industries.
TechLife Capital is accompanied by 10 operating partners, 5 Healthcare specialists and 5 Technology specialists. They are respected CEOs with long experience in the targeted sectors. They assist the team investigating the various market verticals..
Furthermore, TechLife Capital is accompanied by Technology and Healthcare experts, constituting its Scientific Committee and a network of specialists built over more than 20 years of coverage of the Technology and Healthcare industries.
Investment Strategy: proactive investigation of targeted verticals
Our investment approach consists in pre-identifying specific and promising market verticals within the 9 sectors of focus highlighted in Healthcare and Technology. These market verticals are then investigated proactively and thoroughly.
These verticals are often characterized by an accelerating demand, a still fragmented offer, and a clear need for an active player to impact and structure its market segment.
It is therefore an investment strategy based on strong convictions and in-depth investigations of promising sectors.
Value creation in partnering with promising companies
Our role as a catalyst in the transformation of these companies is to help them in their structuring, professionalization, and in the acceleration of their ambitions in order to impact their market vertical, and change league.
We aim at more than doubling the size of the companies, helping them become French leaders, reach European status, and potentially expand globally.
Growth can come from pure organic growth, international expansion, acquisitions or a mix of the three.
Equity financing tailored to the project needs
Once a promising market vertical has been identified and investigated, resulting in the approach of an attractive company, we partner with the management team to define the ambition of the project, the vision, the milestones, the financing requirements and the tailored-made structuring.
As long as we are motivated by the market vertical, excited by the company, its management team and the project, we are very flexible in terms of structuring (capital increase of new equity / acquisition of existing equity, majority / minority position…).
The equity commitments can range from 5M€ to 50M€.
The targeted companies have a French initial dimension, a proven business model, are profitable, have a clear ambition to change scale and status and significantly expand internationally.